• Strategic Use of G-1: Redefining GPR30’s Translational Impac

  2026-06-25

  This article provides a thought-leadership perspective for translational researchers, blending mechanistic insights and strategic guidance on leveraging G-1 (CAS 881639-98-1), a selective GPR30 agonist, to advance discovery in neuropathic pain, cardiovascular, and oncology models. Anchored by the latest evidence, it charts a roadmap for innovative bench-to-bedside research.

• EdU Imaging Kits (Cy5): Precision S-Phase Detection in Neuro

  2026-06-25

  EdU Imaging Kits (Cy5) deliver ultrasensitive, morphology-preserving cell proliferation analysis by leveraging click chemistry for S-phase DNA synthesis measurement. This workflow outperforms traditional BrdU assays, supporting advanced neurodevelopmental, genotoxicity, and pharmacodynamic research with robust, reproducible results.

• AM 281: Precision CB1 Cannabinoid Receptor Antagonist in Neu

  2026-06-24

  AM 281 sets the benchmark for selective CB1 cannabinoid receptor antagonism in cognitive and neuroprotection research. This article navigates experimental design, protocol refinements, and troubleshooting—empowering researchers to unlock the full translational potential of AM 281 in models of memory impairment and traumatic brain injury.

• GPR30 in Spinal CCK+ Neurons: A Target for Neuropathic Pain

  2026-06-23

  This study provides compelling evidence that GPR30, a membrane estrogen receptor, is functionally upregulated in spinal cholecystokinin-positive (CCK+) neurons during neuropathic pain. Targeted inhibition of GPR30 in these neurons significantly attenuates allodynia and synaptic sensitization, highlighting GPR30 as a promising molecular target for pain research.

• Fluorene-9-Bisphenol Inhibits GPER1: Mechanism in Neuroblast

  2026-06-23

  This study uncovers how fluorene-9-bisphenol (BHPF), a BPA substitute, acts as a GPER1 inhibitor to induce apoptosis in human neuroblastoma cells. By integrating molecular modeling, mutagenesis, and functional cell assays, the work delineates a distinct inhibitory mechanism, highlighting implications for both toxicology and endocrine disruption research.

• AL-8810: Precision Tool for Dissecting Prostaglandin F2α Sig

  2026-06-22

  Explore how AL-8810, a potent prostaglandin F2α antagonist, uniquely enables detailed investigation of FP receptor signaling in endometrial and vascular biology. This article delivers advanced protocol insights and strategic guidance for researchers aiming to unravel FP receptor–mediated pathways.

• Doxycycline: Applied Workflows for AAA and Cancer Research

  2026-06-22

  Doxycycline’s dual function as a tetracycline antibiotic and metalloproteinase inhibitor is redefining preclinical workflows in vascular and cancer research. This article unpacks its precise application in advanced drug delivery, with actionable protocol enhancements and troubleshooting strategies for reproducible success.

• Risedronate Sodium: Innovations in Lung-Targeted Bone Therap

  2026-06-21

  Explore how Risedronate Sodium, a potent FPP synthase inhibitor, is reshaping osteoporosis and emphysema research through advanced nano-delivery and pulmonary administration. This article uniquely bridges molecular insights and translational assay design for bone metabolism research.

• miR-18a/ALOXE3 Axis Modulates Ferroptosis and Migration in G

  2026-06-20

  Yang et al. reveal that miR-18a drives glioblastoma progression by downregulating ALOXE3, impairing ferroptotic cell death and enhancing tumor cell migration via Gs protein-coupled signaling. This study identifies a novel regulatory axis in lipid metabolism with implications for targeted glioblastoma research and therapeutic strategies.

• Dextrose (D-glucose): Optimizing Glucose Metabolism Research

  2026-06-19

  Dextrose (D-glucose) is indispensable for advanced cellular metabolism and immunometabolism studies, enabling consistent, high-purity results in challenging experimental contexts. This article delivers actionable protocols, troubleshooting strategies, and translational insights inspired by the latest research and best practices.

• Hypoxia, Immunometabolism, and Tumor Microenvironment Dynami

  2026-06-19

  This review dissects how hypoxia-driven metabolic reprogramming and immune cell adaptation shape the tumor microenvironment (TME), fostering immunosuppression and tumor progression. The findings clarify intricate mechanisms by which glucose metabolism and nutrient competition under hypoxia influence both cancer and immune cells, offering new perspectives for targeted therapeutic strategies.

• DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid): Pro

  2026-06-18

  DIDS enables precise chloride channel modulation for advanced oncology, neuroprotection, and vascular research, with experimentally validated protocols for robust results. This guide translates recent mechanistic breakthroughs into actionable workflows and troubleshooting strategies, making APExBIO’s DIDS a top choice for cutting-edge translational studies.

• Vidarabine Monohydrate: Mechanisms, Efficacy, and Research U

  2026-06-18

  Vidarabine monohydrate (Spongoadenosine monohydrate) is a high-purity antiviral nucleoside analog that inhibits viral DNA synthesis by mimicking adenosine. The compound is DMSO-soluble and widely applied in mechanistic studies of DNA replication interference. Its use is limited to research contexts due to stability and solubility constraints.

• 7-AAD Cell Viability Assay Kit: Precision for CAR-T Research

  2026-06-17

  The 7-AAD Cell Viability Assay Kit empowers researchers to robustly distinguish necrotic and late apoptotic cells in multiplexed flow cytometry and microscopy, with reduced spectral overlap compared to conventional dyes. Its optimized protocol and spectral properties make it the tool of choice for advanced CAR-T and immunotherapy workflows.

• Indole-3-pyruvic Acid: Bridging Plant Hormone and Immune Mod

  2026-06-17

  Explore how Indole-3-pyruvic acid (IPA) serves as a pivotal link between plant hormone biosynthesis and immune modulation via the AhR pathway. This article delivers new insights for researchers seeking advanced applications in plant and biomedical sciences.

15035 records 1/1003 page Next 12345 下5页 Last page